Speech-Language Pathologists in Indian Head, MD Accepting Medicare
2 Speech-Language Pathologists found. Showing 1 - 2
 John Joseph Feeley Jr. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3505 Livingston Rd, Indian Head, MD 20640 Phone: 301-932-6610 Fax: 301-870-3814 |
 Alexandra Bennett, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3535 Livingston Rd, Indian Head, MD 20640 Phone: 301-753-1784 |
News Archive
Mass. reports on people who buy insurance only when sick; Wash. board considers aiding consumers get 'Plan B' referrals; ACLU sues R.I. over electronic records
The Boston Globe: "The number of people who appear to be gaming the state's health insurance system by purchasing coverage only when they are sick quadrupled from 2006 to 2008, according to a long-awaited report released yesterday from the Massachusetts Division of Insurance. The result is that insured residents of Massachusetts wind up paying more for health care, according to the report. … The report was released as state lawmakers consider proposals to make it harder for consumers to jump in and then dump their health insurance coverage" (Lazar, 6/30).
Aastrom to pursue Phase 3 CLI clinical program through FDA SPA process
Aastrom Biosciences, Inc., the leading developer of autologous cellular therapies for the treatment of severe cardiovascular diseases, today announced that the company will pursue a Phase 3 clinical program for its autologous cell therapy for the treatment of critical limb ischemia (CLI) through the U.S. Food and Drug Administration's special protocol assessment (SPA) process. Aastrom is currently completing a Phase 2b clinical trial of its cell therapy in patients with CLI and recently met with FDA officials to discuss plans for the Phase 3 program.
New study reveals that 'imperfect drug penetration' can accelerate pathogens' resistance
Prescribing patients two or more drugs that do not reach the same parts of the body could accelerate a pathogen's resistance to all of the drugs being used in treatment, according to a new study published today in the Proceedings of the National Academy of Sciences.
The influence of prior seasonal coronavirus infection on disease severity in COVID-19
A new study posted to the bioRxiv* server attempted to explore anti-spike IgG responses, Fc-gamma receptor (FcγR) activation, IgG targeting of immunodominant regions, and recall responses due to seasonal hCoV infections in non-hospitalized COVID-19 patients.
› Verified 8 days ago